“Clinical Responses in Patients With Moderate-to-Severe Plaque Psoriasis Following Withdrawal and Re-Treatment With Risankizumab or Switching from Ustekinumab to Risankizumab”. 2017. SKIN The Journal of Cutaneous Medicine 1 (3.1): s5. https://doi.org/10.25251/skin.1.supp.4.